Sunila Pradeep

ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 8

Top Venues

Molecular cancer therapeutics

Cancers

Cancer research

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

This page only lists publications with an associated author ORCID identifier.

Publications

Prachi Gupta, Ishaque Pulikkal Kadamberi, Sonam Mittal, Shirng-Wern Tsaih, Jasmine George, Sudhir Kumar, Dileep K Vijayan, Anjali Geethadevi, Deepak Parashar, Paytsar Topchyan, Lindsey McAlarnen, Brian F Volkman, Weiguo Cui, Kam Y J Zhang, Dolores Di Vizio, Pradeep Chaluvally-Raghavan, Sunila Pradeep
Tumor Derived Extracellular Vesicles Drive T Cell Exhaustion in Tumor Microenvironment through Sphingosine Mediated Signaling and Impacting Immunotherapy Outcomes in Ovarian Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 9 (14) (2022)
Sudhir Kumar, Sonam Mittal, Prachi Gupta, Mona Singh, Pradeep Chaluvally-Raghavan, Sunila Pradeep
Metabolic Reprogramming in Tumor-Associated Macrophages in the Ovarian Tumor Microenvironment. Cancers 14 (21) (2022)
Anjali Geethadevi, Bindu Nair, Deepak Parashar, Zhiqiang Ku, Wei Xiong, Hui Deng, Yongsheng Li, Jasmine George, Donna M McAllister, Yunguang Sun, Ishaque P Kadamberi, Prachi Gupta, Michael B Dwinell, William H Bradley, Janet S Rader, Hallgeir Rui, Robert F Schwabe, Ningyan Zhang, Sunila Pradeep, Zhiqiang An, Pradeep Chaluvally-Raghavan
Oncostatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth. Cancer research 81 (20) (2021)
Sonam Mittal, Prachi Gupta, Pradeep Chaluvally-Raghavan, Sunila Pradeep
Emerging Role of Extracellular Vesicles in Immune Regulation and Cancer Progression. Cancers 12 (12) (2020)
Takahito M Miyake, Sunila Pradeep, Emine Bayraktar, Elaine Stur, Katelyn F Handley, Sherry Y Wu, Cristian Rodríguez-Aguayo, Ju-Seog Lee, Gabriel Lopez-Berestein, Robert L Coleman, Anil K Sood
NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 Inhibitors. Molecular cancer therapeutics 19 (8) (2020)
Deepak Parashar, Bindu Nair, Anjali Geethadevi, Jasmine George, Shirng-Wern Tsaih, Ishaque P Kadamberi, Gopa Kumar Gopinadhan Nair, Yiling Lu, Ramani Ramchandran, Denise S Uyar, Janet S Rader, Prahlad T Ram, Gordon B Mills, Sunila Pradeep, Pradeep Chaluvally-Raghavan
Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 Signaling. Cancer research 80 (24) (2020)
Shaolin Ma, Sunila Pradeep, Alejandro Villar-Prados, Yunfei Wen, Emine Bayraktar, Lingegowda S Mangala, Mark Seungwook Kim, Sherry Y Wu, Wei Hu, Cristian Rodríguez-Aguayo, Carola Leuschner, Xiaoyan Liang, Prahlad T Ram, Katharina Schlacher, Robert L Coleman, Anil K Sood
GnRH-R-Targeted Lytic Peptide Sensitizes BRCA Wild-type Ovarian Cancer to PARP Inhibition. Molecular cancer therapeutics 18 (5) (2019)
Takeshi Hisamatsu, Michael McGuire, Sherry Y Wu, Rajesha Rupaimoole, Sunila Pradeep, Emine Bayraktar, Kyunghee Noh, Wei Hu, Jean M Hansen, Yasmin Lyons, Kshipra M Gharpure, Archana S Nagaraja, Lingegowda S Mangala, Takashi Mitamura, Cristian Rodríguez-Aguayo, Young Gyu Eun, Johnathon Rose, Geoffrey Bartholomeusz, Cristina Ivan, Ju-Seog Lee, Koji Matsuo, Michael Frumovitz, Kwong K Wong, Gabriel Lopez-Berestein, Anil K Sood
PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer. Molecular cancer therapeutics 18 (1) (2018)

Sunila Pradeep.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sunila Pradeep